ResMed posts Q2 net revenue of USD 1.4 billion, up 11%

Reuters
Jan 30
ResMed posts <a href="https://laohu8.com/S/QTWO">Q2</a> net revenue of USD 1.4 billion, up 11%

ResMed Inc. reported financial results for the second quarter ended December 31, 2025. Net revenue for the quarter was USD 1.4 billion, an increase of 11%. Gross margin was 61.8%, while non-GAAP gross margin reached 62.3%. Income from operations increased by 18%. Diluted earnings per share were USD 2.68, with non-GAAP diluted earnings per share at USD 2.81. Operating cash flow for the period was USD 340 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ResMed Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9644991-en) on January 29, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10